As of 2025-09-16, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -13.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 1,061.96 mil USD. TNDM's TTM EBITDA according to its financial statements is -75.89 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 9.7x | 9.4x |
| Forward P/E multiples | 12.9x - 19.3x | 16.6x |
| Fair Price | (18.09) - (14.52) | (18.28) |
| Upside | -249.7% - -220.1% | -251.2% |
| Date | EV/EBITDA |
| 2025-09-11 | -14.62 |
| 2025-09-10 | -14.24 |
| 2025-09-09 | -14.41 |
| 2025-09-08 | -14.36 |
| 2025-09-05 | -14.43 |
| 2025-09-04 | -14.26 |
| 2025-09-03 | -14.22 |
| 2025-09-02 | -14.61 |
| 2025-08-29 | -14.37 |
| 2025-08-28 | -13.73 |
| 2025-08-27 | -14.14 |
| 2025-08-26 | -14.13 |
| 2025-08-25 | -14.01 |
| 2025-08-22 | -13.85 |
| 2025-08-21 | -13.07 |
| 2025-08-20 | -12.74 |
| 2025-08-19 | -12.92 |
| 2025-08-18 | -12.88 |
| 2025-08-15 | -12.86 |
| 2025-08-14 | -12.72 |
| 2025-08-13 | -13.14 |
| 2025-08-12 | -13.12 |
| 2025-08-11 | -12.23 |
| 2025-08-08 | -13.23 |
| 2025-08-07 | -13.49 |
| 2025-08-06 | -16.04 |
| 2025-08-05 | -16.72 |
| 2025-08-04 | -16.96 |
| 2025-08-01 | -16.94 |
| 2025-07-31 | -17.10 |
| 2025-07-30 | -18.07 |
| 2025-07-29 | -18.09 |
| 2025-07-28 | -18.22 |
| 2025-07-25 | -17.38 |
| 2025-07-24 | -16.98 |
| 2025-07-23 | -17.61 |
| 2025-07-22 | -16.86 |
| 2025-07-21 | -16.25 |
| 2025-07-18 | -16.38 |
| 2025-07-17 | -16.90 |
| 2025-07-16 | -17.25 |
| 2025-07-15 | -16.76 |
| 2025-07-14 | -17.25 |
| 2025-07-11 | -17.11 |
| 2025-07-10 | -17.63 |
| 2025-07-09 | -17.34 |
| 2025-07-08 | -18.03 |
| 2025-07-07 | -17.70 |
| 2025-07-03 | -18.17 |
| 2025-07-02 | -18.44 |